Shree Ganesh Biotech India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2.29 | 3.92 | 4.84 |
| Operating Expense | 1.96 | 3.69 | 4.30 |
| Net Profit | 0.32 | 0.24 | 0.54 |
| Net Profit Margin | 13.97 | 6.12 | 11.16 |
| Earning Per Share | 0.01 | 0.01 | 0.01 |
| EBIDTA | 0.32 | 0.24 | 0.54 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2.29 |
| Operating Expense | 1.96 |
| Net Profit | 0.32 |
| Net Profit Margin | 13.97 |
| Earning Per Share | 0.01 |
| EBIDTA | 0.32 |
| Effective Tax Rate | TBA |
Invest in Shree Ganesh Biotech India Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 20.28 | 62.45 | 72.64 |
| Operating Expenses Annual | 20.48 | 60.30 | 69.19 |
| Operating Profit Annual | 0.86 | 2.71 | 3.50 |
| Interest Annual | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 |
| Net Profit Annual | 0.62 | 2.04 | 2.53 |
| Tax Annual | 0.23 | 0.68 | 0.97 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 20.28 |
| Operating Expenses Annual | 20.48 |
| Operating Profit Annual | 0.86 |
| Interest Annual | 0.00 |
| Depreciation | 0.00 |
| Net Profit Annual | 0.62 |
| Tax Annual | 0.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.48 | 0.04 | 0.02 |
| Cash Flow from Operations | 10.16 | 10.54 | 3.57 |
| Cash Flow from Investing | -10.21 | -10.09 | -3.37 |
| Cash Flow from Financing | TBA | TBA | -0.19 |
| Cash Flow at the End | 0.43 | 0.48 | 0.04 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.48 |
| Cash Flow from Operations | 10.16 |
| Cash Flow from Investing | -10.21 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 4.24 | 4.34 | 4.82 |
| PBIT Margin (%) | 4.24 | 4.34 | 4.82 |
| PBT Margin (%) | 4.24 | 4.34 | 4.82 |
| Net PROFIT Margin (%) | 3.06 | 3.27 | 3.48 |
| Return On Networth / Equity (%) | 0.99 | 3.33 | 4.28 |
| Return On Networth /Employed (%) | 1.36 | 4.43 | 5.92 |
| Return On Assets (%) | 0.98 | 3.33 | 4.28 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.32 | 1.02 | 1.23 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 4.24 |
| PBIT Margin (%) | 4.24 |
| PBT Margin (%) | 4.24 |
| Net PROFIT Margin (%) | 3.06 |
| Return On Networth / Equity (%) | 0.99 |
| Return On Networth /Employed (%) | 1.36 |
| Return On Assets (%) | 0.98 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.00 | 0.00 | 0.00 |
| Total Current Assets Annual | 3.73 | 19.84 | 43.97 |
| Non Current Assets Annual | 69.89 | 59.68 | 49.59 |
| Total Shareholders Funds Annual | 62.98 | 62.36 | 60.32 |
| Total Assets Annual | 73.62 | 79.52 | 93.55 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.00 |
| Total Current Assets Annual | 3.73 |
| Non Current Assets Annual | 69.89 |
| Total Shareholders Funds Annual | 62.98 |
| Total Assets Annual | 73.62 |
No Data Availabe
